Basic Sildalis Information

• INN (International Nonproprietary Name): Sildalis does not have an official INN; it is a combination medication containing sildenafil citrate (INN: sildenafil) and tadalafil (INN: tadalafil).
• Brand Names Available In Canada (English): Sildalis is marketed as a non-innovator, mostly internet-sold combination drug that merges the active ingredients of Viagra (sildenafil) and Cialis (tadalafil); packaging often shows red, oval tablets and may be labelled in English or other languages.
• ATC Code: Sildenafil is classified G04BE03 and tadalafil is classified G04BE08 under the ATC system for drugs used in erectile dysfunction.
• Forms & Dosages: Sold as tablets, typical strength is 100 mg sildenafil + 20 mg tadalafil per tablet, commonly packaged in blisters of 6–20 tablets.
• Manufacturers In Canada (English): Not produced by major original manufacturers; most production is by Indian generic companies or direct-to-web suppliers, and it is not available through official Western pharma supply chains.
• Registration Status In Canada (English): Not registered as a fixed combination product with major regulatory agencies; no public record of an approved sildenafil+tadalafil combination holding a drug identification number (DIN).
• OTC / Rx Classification: Both sildenafil and tadalafil are prescription-only (Rx) where regulated; Sildalis is often sold without prescription through unregulated online vendors.

Critical Warnings & Restrictions In Canada

Is this safe for everyone to try?

Sildalis is a fixed combination of sildenafil and tadalafil and is not approved as a combination product by Health Canada according to available registration records.

Combining two PDE5 inhibitors creates a higher theoretical risk of additive adverse effects such as marked hypotension, syncope, and prolonged erection.

No Drug Identification Number (DIN) exists for Sildalis as a combination product, and many online offers are unregulated.

Do not use Sildalis without a medical assessment documenting cardiovascular fitness for sexual activity.

Absolute contraindications include concurrent nitrates (for example, nitroglycerin) and the pulmonary vasodilator riociguat due to life-threatening hypotension risk.

Known allergy to sildenafil, tadalafil, or excipients is an absolute contraindication.

Severe cardiovascular disease that makes sexual activity unsafe is another absolute restriction.

High‑Risk Groups

Elderly patients should start at lower doses and have blood pressure monitored because of increased sensitivity to hypotension.

People with significant hepatic or renal impairment require dose adjustments for the individual agents; the combination product has not been specifically studied.

Recent myocardial infarction, recent stroke, unstable angina, and retinitis pigmentosa are high‑risk conditions where use is usually avoided.

Pregnant or breastfeeding people: Sildalis is not indicated and should not be used.

Interaction With Activities

Dizziness and visual changes are known side effects that can suddenly impair driving or operating machinery.

Advise caution when driving and avoid strenuous tasks until effects and tolerance are known.

Q&A — Can I Drive After Taking It In Canada?

Short answer: Avoid driving if you feel dizzy, light‑headed, or have visual disturbances after taking the medicine.

Effects can be sudden, so do not assume you are safe to drive the first few times you try a dose.

Checklist — Avoid driving if any of the following occur after dosing: dizziness, faintness, blurred vision, colour tinge to vision, severe headache, or sudden weakness.

Usage Basics For Canadians

What exactly is in these tablets people are searching for?

INN & Composition

Sildalis has no official INN and is described in product literature as a non‑innovator combination of sildenafil citrate and tadalafil.

Packaging often shows red, oval tablets and may be labelled in English or other languages depending on the supplier.

Both active substances are established PDE5 inhibitors for erectile dysfunction when used separately.

Brand Names And Availability

Neither Pfizer nor Eli Lilly manufacture Sildalis.

It is marketed by various online generics manufacturers, commonly India‑based, and primarily sold via the internet rather than through licensed Canadian pharmacies.

Legal Classification Under Health Canada

In Canada both sildenafil and tadalafil are prescription drugs and require a prescription for lawful dispensing in licensed pharmacies.

A fixed combination that has not undergone Health Canada review does not have a DIN and is not an approved marketed product in regulated Canadian channels.

• Regulated channels: Licensed Canadian community pharmacies, provincial drug plan pharmacies, hospital pharmacies (require Rx and DIN).
• Unregulated channels: International internet vendors, market places selling without prescription or product verification.

Definition list:

• INN: International Nonproprietary Name for active substances.
• DIN: Drug Identification Number required for marketed drugs in Canada.
• Rx: Prescription-only medicine.

Canadian Dosing Guide

How do people online suggest taking this product, and is that safe?

Standard Regimen

Products sold as Sildalis commonly contain 100 mg sildenafil plus 20 mg tadalafil per tablet and instruct taking one tablet 30–60 minutes before sexual activity, not more than once per 24 hours.

This combined dose exceeds typical starting doses for either agent alone and raises safety concerns due to additive effects.

Adjustments For Comorbidities

For diabetes, cardiovascular disease, liver or kidney impairment, and elderly patients, clinicians generally start at lower doses of sildenafil or tadalafil individually and monitor response and side effects.

Because Sildalis combines both agents at substantial strengths, there is no validated dosing guidance for these comorbid conditions and specialist or pharmacist review is recommended if patients present with the product.

Monitoring

Conduct a baseline cardiovascular risk assessment before initiating PDE5 inhibitors.

Review concomitant medications carefully for nitrates, alpha‑blockers, and strong CYP3A4 inhibitors.

Check blood pressure and counsel patients to seek immediate care for erections lasting longer than four hours (priapism).

Q&A — What If I Miss A Dose Under My Provincial Drug Plan?

As‑needed medications for erectile dysfunction are taken when required, so typical "missed dose" rules do not apply.

If the prescriber has prescribed a daily PDE5 inhibitor regimen, follow prescriber instructions or contact a pharmacist or the provincial drug plan for refill and dosing guidance.

Interaction Chart (Canadian Context)

Which medicines and foods cause trouble when combined with PDE5 inhibitors?

Food & Drink Interactions

Alcohol increases the risk of orthostatic hypotension and may worsen dizziness or fainting with PDE5 inhibitors.

Large or fatty meals can delay the onset of sildenafil.

Grapefruit or grapefruit juice can raise sildenafil and tadalafil levels via CYP interactions and should be avoided or used with caution.

Common Drug Conflicts

Absolute interactions: nitrates and riociguat are contraindicated because of life‑threatening hypotension.

Relative interactions: alpha‑blockers may cause additive blood pressure reduction and require careful monitoring and dosing adjustments.

Potent CYP3A4 inhibitors such as ritonavir or ketoconazole can significantly increase PDE5 inhibitor concentrations and may require dose reduction or avoidance.

Antihypertensives and certain protease inhibitors may increase hypotensive effects and should be monitored.

Checklist for clinicians and patients: ask specifically about nitrates, heart medications, HIV antiretrovirals, and recent heart attack or stroke.

Suggested quick reference table for clinicians and patients:

User Reports & Trends In Canada

Why do Canadians keep searching for this product online?

Online search trends show Sildalis frequently appears as an "enhanced potency" dual‑action pill advertised on international websites.

Many offers originate outside regulated supply chains, which drives patient interest but also raises safety concerns about authenticity and dosing.

Canadian Patient Forums & Review Platforms

Expect anecdotal posts reporting perceived efficacy and varying side effects, but forum reports are unverified and prone to bias.

Clinicians should caution patients that forum-sourced products may be counterfeit or substandard.

Community Pharmacy Feedback

Pharmacists commonly receive questions about sourcing, unlabelled products, and requests to substitute unapproved combinations with regulated sildenafil or tadalafil.

Many pharmacists will decline to dispense unapproved combination products without a valid prescription and product verification.

• Typical patient statements pharmacists hear: "It worked better than Viagra," "I ordered it online without a prescription," "The pill looks different than my prescription tablets."
• Checklist for pharmacists when patients present online purchases: verify product labelling and DIN, confirm manufacturer and lot number, advise clinical assessment before further use.

Access & Purchase Options

Where should Canadians buy erectile dysfunction medication to stay safe and legal?

In‑Store

National chains such as Shoppers Drug Mart, Rexall, London Drugs, and Jean Coutu dispense prescription PDE5 inhibitors with a valid prescription.

These retailers provide products with DINs, bilingual labelling where applicable, and pharmacist counselling at the point of sale.

Online Pharmacies & Provincial Restrictions

Licensed Canadian online pharmacies require a prescription and ship regulated products through Canadian distribution channels.

Many Sildalis offers come from international or unverified vendors that may ship without prescription and bypass provincial dispensing safeguards.

Practical patient checklist when purchasing: always obtain a prescription, use a licensed Canadian pharmacy, verify DIN on the product, check packaging and bilingual labelling where appropriate, and keep receipts and counselling notes.

In our online pharmacy, sildalis is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Mechanism & Pharmacology

How do the drugs in Sildalis work, and what is the pharmacology behind combining them?

Patient‑Friendly Mechanism

Both sildenafil and tadalafil inhibit phosphodiesterase type 5 (PDE5), which increases cyclic GMP and promotes vasodilation and increased blood flow to the penis during sexual stimulation.

Combining the two may theoretically prolong or intensify erectile response but also increases the chance of adverse effects due to additive pharmacologic action.

Clinical Terms & References

Sildenafil (ATC G04BE03) typically acts faster and for a shorter duration than tadalafil (ATC G04BE08), which has a longer half‑life and duration of effect.

No formal pharmacokinetic studies exist for the fixed‑dose Sildalis combination, and combined interactions and additive effects are not well characterised.

Definitions:

• PDE5: Enzyme that breaks down cGMP; inhibition enhances erection physiology.
• Onset: Time until effect starts — sildenafil acts faster.
• Half‑Life: Time for plasma concentration to halve — tadalafil is longer acting.

Indications & Off-Label Uses In Canada

What are these pills approved to treat in Canada?

Approved Indications

Individual agents—sildenafil and tadalafil—are approved for erectile dysfunction when dispensed under a DIN in Canada.

Tadalafil also has approved uses for benign prostatic hyperplasia symptoms and selected pulmonary arterial hypertension indications depending on formulation and registration.

Sildalis as a fixed sildenafil+tadalafil product is not registered and has no recognised indication or DIN in Canada.

Off‑Label Practices

Some prescribers may use tadalafil as a daily therapy or sildenafil as needed individually, but combining both agents in a single fixed dose is not standard practice.

The lack of safety data and potential for additive adverse effects make routine combination use inadvisable.

• Approved single‑agent options: sildenafil for ED, tadalafil for ED and BPH where indicated.
• Off‑label combination pros: theoretical longer coverage or potency.
• Off‑label combination cons: unknown PK, increased hypotension risk, no regulatory oversight.

Key Clinical Findings

What does the evidence say about safety and effectiveness?

Evidence Summary

No Health Canada‑registered clinical trials validate the safety or efficacy of the fixed sildenafil+tadalafil combination product Sildalis.

Robust literature supports each active ingredient individually for erectile dysfunction, but high‑quality data on the fixed‑dose combination are lacking.

Canadian/International Monitoring

Health Canada and pharmacovigilance systems monitor adverse events related to PDE5 inhibitors generally, and clinicians should report suspected events tied to unapproved combination products.

Until randomized controlled trial data exist for the combination, clinicians should consider the combination unsupported by regulatory evidence and counsel patients accordingly.

• Known: Sildenafil and tadalafil individually are effective for ED when appropriately prescribed.
• Unknown: Combined pharmacokinetics, additive safety profile at fixed high doses.
• Action for clinicians: report adverse events, document counselling, recommend regulated alternatives.

Alternatives Matrix

What are safer, regulated options in Canada?

Comparable Medicines With DIN In Canada

Approved, DIN‑bearing medications include Viagra (sildenafil), Cialis (tadalafil), Levitra (vardenafil), and multiple generics for sildenafil and tadalafil.

These single‑agent therapies offer predictable pharmacology, established dosing, and regulated manufacturing.

Pros & Cons Checklist

Pharmacist checklist for switching or initiating therapy: verify diagnosis, assess cardiovascular risk, review medications for interactions, start at the lowest effective dose, and document counselling.

Common Questions From Canadian Patients

Patients often want quick, practical answers.

• Is Sildalis approved in Canada? No; it is not registered and lacks a DIN.
• Can I substitute Sildalis for Viagra or Cialis? Clinicians generally recommend approved single agents with established safety profiles rather than an unapproved combination.
• Is it safe to buy online? Only buy from licensed Canadian pharmacies that require a prescription; international vendors that ship without Rx carry higher risk.

Other concerns include cost, privacy, efficacy, and how to get refills under provincial drug plans.

Advise immediate emergency care for priapism (erection >4 hours) or signs of severe hypotension such as fainting or chest pain.

Coverage & Purchase Comparison Table

Will provincial drug plans cover this product?

Coverage Overview

Provincial drug plans generally do not list unapproved combination products and require a DIN for formal coverage.

PDE5 inhibitors may be covered in select circumstances or via special authorization, but coverage varies by plan and patient category.

Suggested Table

Step‑by‑step purchase checklist:

1. Obtain a prescription from a licensed prescriber.
2. Check the product for a valid DIN on the packaging.
3. Use a licensed Canadian pharmacy for dispensing.
4. Verify provincial coverage or private insurance for the prescribed product.
5. Keep a record of pharmacist counselling and receipts.

Registration & Regulation

Is this product legal and regulated in Canada?

Health Canada Approval

Sildalis as a fixed combination product is not registered with Health Canada and has no DIN according to available regulatory records.

Sildenafil and tadalafil individually are regulated prescription drugs and require appropriate labeling and DINs when marketed in Canada.

Labelling & Legal Requirements

Products sold in Canada must meet Canadian labelling requirements, bilingual labelling where applicable, and pharmacy‑dispensing rules.

Imported or internet‑sourced unapproved medicines often fail these requirements and should prompt counselling and verification by a pharmacist.

Checklist for verifying legally compliant products: confirm manufacturer name, DIN, lot number, and expiry date.

Storage & Handling

How should patients store and inspect their tablets?

Household Storage

Store below 30°C (86°F), away from moisture and direct sunlight.

Keep all medicines out of reach of children and pets.

Shipping And Transport

Prefer licensed pharmacies that follow Canadian distribution channels for online orders.

Suspect products with poor packaging, missing lot numbers, or inconsistent labelling and report concerns to the dispensing pharmacist.

Checklist on receipt: check DIN and label, compare tablet appearance to product images, confirm expiry and lot number, and contact the pharmacy if anything looks different.

Dispose of expired or unused tablets through a pharmacy take‑back program or local hazardous waste instructions.

Guidelines For Proper Use

How should pharmacists and clinicians manage patients who ask about Sildalis?

Pharmacist Guidance

Perform a medication review focusing on nitrates, riociguat, alpha‑blockers, and CYP3A4 inhibitors.

Counsel on common side effects such as headache, flushing, nasal congestion, visual changes, and back pain.

Advise on timing relative to meals and alcohol and document counselling in the patient record.

Warn patients against unverified online purchases and explain how to report adverse events to Health Canada.

Provincial Health Authority Recommendations

Adhere to provincial formularies and refer to specialists for complex cardiac patients or those with multiple comorbidities.

If a patient insists on using Sildalis, offer regulated single‑agent alternatives and explain the lack of approval and unknown safety profile.

• Clinician checklist: assess cardiovascular risk, review interactions, start low for elderly or impaired patients, monitor blood pressure, and report adverse events.
• Patient "what to do if" flowchart: adverse effects — stop medication and seek care; priapism — seek emergency care immediately.

Delivery Across Canada (English)